MedPath

The comparison of the effect of tetracycline sterile ophthalmic ointment as an adjvant in peri-implantitis treatment

Phase 2
Conditions
peri-implantitis.
Other endosseous dental implant failure
M27.69
Registration Number
IRCT20210909052418N1
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
32
Inclusion Criteria

Presence of pre-implant disease
No history of pre-implant surgery treatment
PD>6 mm
Positive BOP
BOL<2mm
No use of antibiotics and mouthwash and periodontal treatment in the last 6 weeks. No use of antibiotics and mouthwash and periodontal treatment in the last 6 weeks

Exclusion Criteria

Pregnancy and breast feeding
Using anticoagulants
Allergy to tetracycline sterile eye ointment
Underlying disease (diabetes, kidney disorders, etc.)
Smoking

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Presence or absence of plaque on tooth and implant surfaces (mesial, distal, buccal and lingual surfaces). Timepoint: 1 and 3 months after the intervention. Method of measurement: Clinical dental examination.;The distance between the gingival margin and the depth of the envelope is in millimeters. Timepoint: 1 and 3 months after the intervention. Method of measurement: Clinical dental examination.;Presence or absence of bleeding after probing. Timepoint: 1 and 3 months after the intervention. Method of measurement: Clinical dental examination.;The distance between the acrylic stent and the depth of the pocket. Timepoint: 1 and 3 months after the intervention. Method of measurement: Clinical dental examination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath